ACLARION, INC. (ACON) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $25.00; Additional Paid in CapitalUSD $81.10M; Retained Earnings (Accumulated Deficit)USD $-64.10M; Stockholders' Equity Attributable to ParentUSD $17.00M.
- 2026-03-31: Common Stock, Value, IssuedUSD $25.00; Additional Paid in CapitalUSD $81.00M; Retained Earnings (Accumulated Deficit)USD $-61.35M; Stockholders' Equity Attributable to ParentUSD $19.65M.
- 2025-12-31: Common Stock, Value, IssuedUSD $9.00; Additional Paid in CapitalUSD $71.33M; Retained Earnings (Accumulated Deficit)USD $-58.50M; Stockholders' Equity Attributable to ParentUSD $12.84M.
- 2025-09-30: Common Stock, Value, IssuedUSD (m); Additional Paid in CapitalUSD $69.11M; Retained Earnings (Accumulated Deficit)USD $-56.61M; Stockholders' Equity Attributable to ParentUSD $12.50M.
ACLARION, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Adjustments to Additional Paid in Capital, Other USD | Additional Paid in Capital, Preferred Stock USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $25.00 | $81.10M | $-64.10M | $17.00M | 3 month · $6.33K | 3 month · $102.12K | (m) | 6 month · $698.06K | (m) | (m) | (m) |
| 2026-03-31 | $25.00 | $81.00M | $-61.35M | $19.65M | 3 month · $691.74K | 3 month · $4.69K | (m) | 3 month · $691.74K | (m) | (m) | (m) |
| 2025-12-31 | $9.00 | $71.33M | $-58.50M | $12.84M | (m) | 12 month · $105.37K | (m) | 12 month · $2.40M | (m) | (m) | (m) |
| 2025-09-30 | (m) | $69.11M | $-56.61M | $12.50M | (m) | 3 month · $16.75K | (m) | 3 month · $0.00 | (m) | (m) | (m) |
| 2025-06-30 | (m) | $69.09M | $-54.90M | $14.19M | 3 month · $18.15K | 3 month · $28.36K | (m) | 3 month · $18.15K | (m) | (m) | (m) |
| 2025-03-31 | (m) | $69.08M | $-53.30M | $15.78M | 3 month · $2.10M | 3 month · $55.90K | 3 month · $336.44K | 3 month · $2.10M | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $52.23M | $-51.26M | $970.06K | (m) | 12 month · $287.45K | (m) | 12 month · $1.10M | (m) | (m) | (m) |
| 2024-09-30 | $100.00 | $51.78M | $-49.27M | $2.51M | (m) | 3 month · $74.71K | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $82.00 | $49.56M | $-47.92M | $1.64M | (m) | 3 month · $70.31K | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $72.00 | $49.19M | $-46.68M | $2.51M | (m) | 3 month · $85.83K | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $8.00 | $43.55M | $-44.28M | $-728.00K | (m) | 12 month · $456.00K | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $82.00 | $42.19M | $-43.02M | $-827.98K | (m) | 3 month · $137.31K | 3 month · $22.50K | (m) | (m) | (m) | (m) |
| 2023-06-30 | $82.00 | $42.03M | $-42.02M | $10.22K | (m) | 3 month · $136.63K | 3 month · $37.50K | 3 month · $37.50K | (m) | (m) | (m) |
| 2023-03-31 | $79.00 | $41.68M | $-40.55M | $1.13M | (m) | 3 month · $82.53K | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $5.00 | $41.60M | $-39.37M | $2.23M | (m) | 12 month · $1.19M | 12 month · $1.28K | 12 month · $-530.46K | $0.00 | (m) | (m) |
| 2022-09-30 | $78.00 | $41.36M | $-38.43M | $2.93M | (m) | 3 month · $326.20K 9 month · $1.05M | 9 month · $1.28K | (m) | $0.00 | (m) | (m) |
| 2022-06-30 | $78.00 | $41.03M | $-36.79M | $4.24M | (m) | 3 month · $701.50K | 3 month · $1.28K | 3 month · $-530.46K | $0.00 | $0.00 | 6 month · $724.63K |
| 2022-03-31 | $9.00 | (m) | $-33.11M | $-14.03M | (m) | 3 month · $23.12K | (m) | (m) | $7.10M | $7.10M | (m) |
| 2021-12-31 | $9.00 | $19.05M | $-31.89M | $-12.83M | (m) | 12 month · $177.49K | 12 month · $30.39K | (m) | $7.10M | $7.10M | (m) |
| 2021-09-30 | (m) | (m) | (m) | $-11.61M | (m) | 9 month · $93.48K | 9 month · $30.39K | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | $-8.45M | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $9.46K |
| 2021-03-31 | (m) | (m) | (m) | $-7.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | $-7.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |